use of vaginal misoprostol for cervical ripening
Phase 2
Recruiting
- Conditions
- Diseases of the genitourinary system.Excessive, frequent and irregular menstruation
- Registration Number
- IRCT201110084868N3
- Lead Sponsor
- vice- chancellor for research , Qazvin univercity of medical sciences and health services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Inclusion criteria :patints with abnormal uterine bleeding who are candidate for dilation and curretage
exclusion criteria :systemic diseases ; cervical and vaginal infections; history of allergy to prostaglandins ; sever anemia or coagulopathy; anticoagulant therapy; history of cervical surgery;pregnancy; lactation; menopause; suspicious endocervical or exocervical erosions;
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dilation of cervix as much as hegar dilator numbr five. Timepoint: four hour after using drug. Method of measurement: passage of hegar dilator numbr five.
- Secondary Outcome Measures
Name Time Method Decrease in operation time. Timepoint: During operation. Method of measurement: Measurement with chronometer.